AI assistant
Medpace Holdings, Inc. — Director's Dealing 2021
Jul 26, 2021
30442_dirs_2021-07-26_9c4246d0-4e01-498f-bb42-6a08be8c2fd2.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: Medpace Holdings, Inc. (MEDP)
CIK: 0001668397
Period of Report: 2021-07-22
Reporting Person: Medpace Investors, LLC (10% Owner)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2021-07-22 | Common Stock | S | 8516 | $180.63 | Disposed | 6109621 | Direct |
| 2021-07-23 | Common Stock | S | 18882 | $181.21 | Disposed | 6090739 | Direct |
Footnotes
F1: The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 12, 2021.
F2: The reported price is a weighted average price. These shares were sold in multiple transactions ranging from $180.00 to $183.89. The Reporting Person undertakes to provide full pricing information to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission upon request.
F3: The reported price is a weighted average price. These shares were sold in multiple transactions ranging from $180.00 to $182.33. The Reporting Person undertakes to provide full pricing information to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission upon request.